Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy

The tumor microenvironment contributes to disease progression through multiple mechanisms, including immune suppression mediated in part by fibroblast activation protein (FAP)-expressing cells. Herein, a review of FAP biology is presented, supplemented with primary data. This includes FAP expression...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Immunotherapy
Autores principales: Brennen, W Nathaniel, J Thorek, Daniel L, Jiang, Wen, Krueger, Timothy E, Antony, Lizamma, Denmeade, Samuel R, Isaacs, John T
Formato: Artigo
Lenguaje:Inglês
Publicado: Future Medicine Ltd 2020
Materias:
Special Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8008208/
https://ncbi.nlm.nih.gov/pubmed/33148078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0066
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares